These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9589189

  • 1. Thrombin inhibition and intracoronary thrombus formation: effect of polyethylene glycol-coupled hirudin in the stenosed, locally injured canine coronary artery.
    Rübsamen K, Kirchengast M.
    Coron Artery Dis; 1998; 9(1):35-42. PubMed ID: 9589189
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
    Rübsamen K, Hornberger W, Kirchengast M.
    Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122
    [Abstract] [Full Text] [Related]

  • 3. Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery.
    Mehta JL, Chen L, Nichols WW, Mattsson C, Gustafsson D, Saldeen TG.
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):345-51. PubMed ID: 9514177
    [Abstract] [Full Text] [Related]

  • 4. Prevention of early reocclusion after thrombolysis of copper coil-induced thrombi in the canine carotid artery: comparison of PEG-hirudin and unfractionated heparin.
    Rübsamen K, Hornberger W.
    Thromb Haemost; 1996 Jul; 76(1):105-10. PubMed ID: 8819261
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic and safety results of PEG-Hirudin in healthy volunteers.
    Esslinger HU, Haas S, Maurer R, Lassmann A, Dübbers K, Müller-Peltzer H.
    Thromb Haemost; 1997 May; 77(5):911-9. PubMed ID: 9184402
    [Abstract] [Full Text] [Related]

  • 6. Platelet and fibrin deposition on coronary stents in minipigs: effect of hirudin versus heparin.
    Buchwald AB, Sandrock D, Unterberg C, Ebbecke M, Nebendahl K, Lüders S, Munz DL, Wiegand V.
    J Am Coll Cardiol; 1993 Jan; 21(1):249-54. PubMed ID: 7678021
    [Abstract] [Full Text] [Related]

  • 7. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis.
    Nicolini FA, Lee P, Rios G, Kottke-Marchant K, Topol EJ.
    Circulation; 1994 Apr; 89(4):1802-9. PubMed ID: 8149546
    [Abstract] [Full Text] [Related]

  • 8. Failure of thrombin inhibition to prevent intracoronary thrombosis in the dog.
    Belcher PR, Drake-Holland AJ, Hynd JW, Noble MI.
    Clin Sci (Lond); 1996 May; 90(5):363-8. PubMed ID: 8665773
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis.
    Nicolini FA, Lee P, Malycky JL, Lefkovits J, Kottke-Marchant K, Plow EF, Topol EJ.
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):39-48. PubMed ID: 8845461
    [Abstract] [Full Text] [Related]

  • 10. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 11. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. II. Adjunctive therapy with r-hirudin.
    Rote WE, Mu DX, Bates ER, Nedelman MA, Lucchesi BR.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):203-11. PubMed ID: 7511748
    [Abstract] [Full Text] [Related]

  • 12. Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis.
    Martin U, Dörge L, Fischer S.
    Br J Pharmacol; 1996 May; 118(2):271-6. PubMed ID: 8735626
    [Abstract] [Full Text] [Related]

  • 13. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
    Ohyama T, Hori T, Moriike M, Asano T, Hayashi H, Iwade K, Hosoda S.
    Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
    [Abstract] [Full Text] [Related]

  • 14. Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis.
    Rigel DF, Olson RW, Lappe RW.
    Circ Res; 1993 May; 72(5):1091-102. PubMed ID: 8477521
    [Abstract] [Full Text] [Related]

  • 15. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, Cui K, Maffrand JP, Campbell WB, Buja LM.
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [Abstract] [Full Text] [Related]

  • 16. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain.
    McGhie AI, McNatt J, Ezov N, Cui K, Mower LK, Hagay Y, Buja LM, Garfinkel LI, Gorecki M, Willerson JT.
    Circulation; 1994 Dec; 90(6):2976-81. PubMed ID: 7994845
    [Abstract] [Full Text] [Related]

  • 17. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty.
    Meyer BJ, Fernández-Ortiz A, Mailhac A, Falk E, Badimon L, Michael AD, Chesebro JH, Fuster V, Badimon JJ.
    Circulation; 1994 Nov; 90(5):2474-80. PubMed ID: 7955205
    [Abstract] [Full Text] [Related]

  • 18. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W.
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [Abstract] [Full Text] [Related]

  • 19. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
    Kirchengast M, Rübsamen K, Lehmann HD.
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):687-94. PubMed ID: 7506319
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.